Tumor Ablation Market: Insights
The global tumor ablation market is estimated to witness a significant CAGR during the forecast period (2019-2026). Rising prevalence of cancer and growing high demand for safer therapeutic are some of the major factors driving the market growth for tumor ablation. According to the data published by WHO, it is projected that 10 to 11 million cancer cases will be diagnosed each year globally, till 2030.
Tumor Ablation Market: By Technology
On the basis of technology, the global tumor ablation market is segmented into radiofrequency ablation, microwave ablation, Cryoablation, and Irreversible Electroporation, among others. The report contains quantitative insights about the following:
- Introduction
- Tumor Ablation Market, By Technology, 2018-2026 (USD Million)
- Radiofrequency Ablation
- Radiofrequency Ablation: Tumor Ablation Market, 2018-2026 (USD Million)
- Microwave Ablation
- Microwave Ablation: Tumor Ablation Market, 2018-2026 (USD Million)
- Cryoablation
- Cryoablation: Tumor Ablation Market, 2018-2026 (USD Million)
- Irreversible Electroporation
- Irreversible Electroporation: Tumor Ablation Market, 2018-2026 (USD Million)
- Other Ablation Technologies
- Other Ablation Technologies: Tumor Ablation Market, 2018-2026 (USD Million)
Tumor Ablation Market: By Treatment
On the basis of treatment, the global tumor ablation market is segmented into surgical ablation, percutaneous ablation and laparoscopic ablation. The report contains quantitative insights about the following:
- Introduction
- Tumor Ablation Market, By Treatment, 2018-2026 (USD Million)
- Surgical Ablation
- Surgical Ablation: Tumor Ablation Market, 2018-2026 (USD Million)
- Laparoscopic Ablation
- Laparoscopic Ablation: Tumor Ablation Market, 2018-2026 (USD Million)
- Percutaneous Ablation
- Percutaneous Ablation: Tumor Ablation Market, 2018-2026 (USD Million)
Tumor Ablation Market: By Application
On the basis of application, the global tumor ablation market is segmented into Kidney Cancer, Liver Cancer and others. The report contains quantitative insights about the following:
- Introduction
- Tumor Ablation Market, By Application, 2018-2026 (USD Million)
- Kidney Cancer
- Kidney Cancer: Tumor Ablation Market, 2018-2026 (USD Million)
- Liver Cancer
- Liver Cancer: Tumor Ablation Market, 2018-2026 (USD Million)
- Breast Cancer
- Breast Cancer: Tumor Ablation Market, 2018-2026 (USD Million)
- Lung Cancer
- Lung Cancer: Tumor Ablation Market, 2018-2026 (USD Million)
- Prostate Cancer
- Prostate Cancer: Tumor Ablation Market, 2018-2026 (USD Million)
- Others
- Others: Tumor Ablation Market, 2018-2026 (USD Million)
Tumor Ablation Market: By Region
On the basis of region, the global Tumor Ablation market is segmented into North America, Europe, Asia Pacific, Central & South America and Middle East & Africa. The countries covered include: U.S., Canada, Mexico, Germany, France, UK, Italy, Spain, China, India, Japan, South Korea, Australia, Brazil, Saudi Arabia, UAE, and South Africa among others. The report provides qualitative & quantitative insights both at a regional as well as country level.
- Introduction
- Global Tumor Ablation Market, Regional Analysis, 2018-2026 (USD Million)
- North America
- North America Tumor Ablation Market, Regional Analysis, 2018-2026 (USD Million)
- By Technology
- North America Tumor Ablation Market, By Technology, 2018-2026 (USD Million)
- By Application
- North America Tumor Ablation Market, By Application, 2018-2026 (USD Million)
- By Treatment
- North America Tumor Ablation Market, By Treatment, 2018-2026 (USD Million)
- By Country
- U.S.
- By Technology
- U.S Tumor Ablation Market, By Technology, 2018-2026 (USD Million)
- By Application
- U.S Tumor Ablation Market, By Application, 2018-2026 (USD Million)
- By Treatment
- U.S Tumor Ablation Market, By Treatment, 2018-2026 (USD Million)
- Canada.
- By Technology
- Canada Tumor Ablation Market, By Technology, 2018-2026 (USD Million)
- By Application
- Canada Tumor Ablation Market, By Application, 2018-2026 (USD Million)
- By Treatment
- Canada Tumor Ablation Market, By Treatment, 2018-2026 (USD Million)
- Mexico
- By Technology
- Mexico Tumor Ablation Market, By Technology, 2018-2026 (USD Million)
- By Application
- Mexico Tumor Ablation Market, By Application, 2018-2026 (USD Million)
- By Treatment
- Mexico Tumor Ablation Market, By Treatment, 2018-2026 (USD Million)
- Europe
- Europe Tumor Ablation Market, Regional Analysis, 2018-2026 (USD Million)
- By Technology
- Europe Tumor Ablation Market, By Technology, 2018-2026 (USD Million)
- By Application
- Europe Tumor Ablation Market, By Application, 2018-2026 (USD Million)
- By Treatment
- Europe Tumor Ablation Market, By Treatment, 2018-2026 (USD Million)
- By Country
- Germany
- By Technology
- Germany Tumor Ablation Market, By Technology, 2018-2026 (USD Million)
- By Application
- Germany Tumor Ablation Market, By Application, 2018-2026 (USD Million)
- By Treatment
- Germany Tumor Ablation Market, By Vertical, 2018-2026 (USD Million)
- UK
- By Technology
- UK Tumor Ablation Market, By Technology, 2018-2026 (USD Million)
- By Application
- UK Tumor Ablation Market, By Application, 2018-2026 (USD Million)
- By Treatment
- UK Tumor Ablation Market, By Treatment, 2018-2026 (USD Million)
- France
- By Technology
- France Tumor Ablation Market, By Technology, 2018-2026 (USD Million)
- By Application
- France Tumor Ablation Market, By Application, 2018-2026 (USD Million)
- By Treatment
- France Tumor Ablation Market, By Treatment, 2018-2026 (USD Million)
- Italy
- By Technology
- Italy Tumor Ablation Market, By Technology, 2018-2026 (USD Million)
- By Application
- Italy Tumor Ablation Market, By Application, 2018-2026 (USD Million)
- By Treatment
- Italy Tumor Ablation Market, By Treatment, 2018-2026 (USD Million)
- Spain
- By Technology
- Spain Tumor Ablation Market, By Technology, 2018-2026 (USD Million)
- By Application
- Spain Tumor Ablation Market, By Application, 2018-2026 (USD Million)
- By Treatment
- Spain Tumor Ablation Market, By Treatment, 2018-2026 (USD Million)
- Rest Of Europe
- By Technology
- Rest Of Europe Tumor Ablation Market, By Technology, 2018-2026 (USD Million)
- By Application
- Rest Of Europe Tumor Ablation Market, By Application, 2018-2026 (USD Million)
- By Treatment
- Rest Of Europe Tumor Ablation Market, By Treatment, 2018-2026 (USD Million)
- Asia Pacific
- Asia Pacific Tumor Ablation Market, Regional Analysis, 2018-2026 (USD Million)
- By Technology
- Asia Pacific Tumor Ablation Market, By Technology, 2018-2026 (USD Million)
- By Application
- Asia Pacific Tumor Ablation Market, By Application, 2018-2026 (USD Million)
- By Treatment
- Asia Pacific Tumor Ablation Market, By Treatment, 2018-2026 (USD Million)
- By Country
- China
- By Technology
- China Tumor Ablation Market, By Technology, 2018-2026 (USD Million)
- By Application
- China Tumor Ablation Market, By Application, 2018-2026 (USD Million)
- By Treatment
- China Tumor Ablation Market, By Treatment, 2018-2026 (USD Million)
- Japan
- By Technology
- Japan Tumor Ablation Market, By Technology, 2018-2026 (USD Million)
- By Application
- Japan Tumor Ablation Market, By Application, 2018-2026 (USD Million)
- By Treatment
- Japan Tumor Ablation Market, By Treatment, 2018-2026 (USD Million)
- India
- By Technology
- India Tumor Ablation Market, By Technology, 2018-2026 (USD Million)
- By Application
- India Tumor Ablation Market, By Application, 2018-2026 (USD Million)
- By Treatment
- India Tumor Ablation Market, By Treatment, 2018-2026 (USD Million)
- South Korea
- By Technology
- South Korea Tumor Ablation Market, By Technology, 2018-2026 (USD Million)
- By Application
- South Korea Tumor Ablation Market, By Application, 2018-2026 (USD Million)
- By Treatment
- South Korea Tumor Ablation Market, By Treatment, 2018-2026 (USD Million)
- Rest Of APAC
- By Technology
- Rest Of APAC Tumor Ablation Market, By Technology, 2018-2026 (USD Million)
- By Application
- Rest Of APAC Tumor Ablation Market, By Application, 2018-2026 (USD Million)
- By Treatment
- Rest Of APAC Tumor Ablation Market, By Treatment, 2018-2026 (USD Million)
- Central & South America
- Central & South America Tumor Ablation Market, Regional Analysis, 2018-2026 (USD Million)
- By Technology
- Central & South America Tumor Ablation Market, By Technology, 2018-2026 (USD Million)
- By Application
- Central & South America Tumor Ablation Market, By Application, 2018-2026 (USD Million)
- By Treatment
- Central & South America Tumor Ablation Market, By Treatment, 2018-2026 (USD Million)
- By Country
- Brazil
- By Technology
- Brazil Tumor Ablation Market, By Technology, 2018-2026 (USD Million)
- By Application
- Brazil Tumor Ablation Market, By Application, 2018-2026 (USD Million)
- By Treatment
- Brazil Tumor Ablation Market, By Treatment, 2018-2026 (USD Million)
- Middle East & Africa
- Middle East & Africa Tumor Ablation Market, Regional Analysis, 2018-2026 (USD Million)
- By Technology
- Middle East & Africa Tumor Ablation Market, By Technology, 2018-2026 (USD Million)
- By Application
- Middle East & Africa Tumor Ablation Market, By Application, 2018-2026 (USD Million)
- By Treatment
- Middle East & Africa Tumor Ablation Market, By Treatment, 2018-2026 (USD Million)
- By Country
- Saudi Arabia
- By Technology
- Saudi Arabia Tumor Ablation Market, By Technology, 2018-2026 (USD Million)
- By Application
- Saudi Arabia Tumor Ablation Market, By Application, 2018-2026 (USD Million)
- By Treatment
- Saudi Arabia Tumor Ablation Market, By Treatment, 2018-2026 (USD Million)
- UAE
- By Technology
- UAE Tumor Ablation Market, By Technology, 2018-2026 (USD Million)
- By Application
- UAE Tumor Ablation Market, By Application, 2018-2026 (USD Million)
- By Treatment
- UAE Tumor Ablation Market, By Treatment, 2018-2026 (USD Million)
Tumor Ablation Market: End Use Landscape
The end-user landscape entails a list of current and prospective consumers prevailing across the regions. This section briefs you about company addresses, contact details, products, and regional presence of companies who are purchasing or are likely to purchase Tumor Ablation. The key end-users of the markets are Mayo clinic, Moffitt Cancer Center and Research Institute and UCLA Medical Center among others.
Tumor Ablation Market: Vendor Landscape
The report contains a chapter dedicated to vendors operating in the market, covering raw material manufactures, equipment developers, manufacturers, and distributors. The report provides these insights on a regional level. This section of the report entails contact details, experience, products manufactured/supplied, and geographical presence of companies.
Tumor Ablation Market: Share & Competitor Analysis
Some of the key players operating in the Tumor Ablation market Galil Medical Inc.; Misonix Inc.; HealthTronics; Angiodynamics (Covidien); Boston Scientific Corporation; Medtronic Plc.; SonaCare Medical; EDAP TMS S.A.; and Neuwave Medical Inc., among others.
Please note: This is not an exhaustive list of companies profiled in the report.
The desk research involved a robust background study which meant referring to paid and unpaid databases to understand the market dynamics; mapping contracts from press releases; identifying the key players in the market, studying their product portfolio, competition level, annual reports/SEC filings & investor presentations; and learning the demand and supply side analysis for the Tumor Ablation market.
The primary research activity included telephonic conversations with more than 50 tier 1 industry consultants, distributors, and end-use product manufacturers.
Finally, based on the above thorough research process, an in-depth analysis was carried out considering the following aspects: market attractiveness, current & future market trends, market share analysis, SWOT analysis of the companies and customer analytics.